"Double-Blind Method" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment.
| Descriptor ID |
D004311
|
| MeSH Number(s) |
E05.318.780.300 E05.581.500.300 N05.715.360.780.320 N06.850.520.445.300
|
| Concept/Terms |
Double-Blind Method- Double-Blind Method
- Double Blind Method
- Double-Blind Methods
- Method, Double-Blind
- Methods, Double-Blind
- Double-Masked Method
- Double Masked Method
- Double-Masked Methods
- Method, Double-Masked
- Methods, Double-Masked
- Double-Masked Study
- Double Masked Study
- Double-Masked Studies
- Studies, Double-Masked
- Study, Double-Masked
- Double-Blind Study
- Double Blind Study
- Double-Blind Studies
- Studies, Double-Blind
- Study, Double-Blind
|
Below are MeSH descriptors whose meaning is more general than "Double-Blind Method".
Below are MeSH descriptors whose meaning is more specific than "Double-Blind Method".
This graph shows the total number of publications written about "Double-Blind Method" by people in this website by year, and whether "Double-Blind Method" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 17 | 17 |
| 1996 | 0 | 16 | 16 |
| 1997 | 0 | 30 | 30 |
| 1998 | 0 | 16 | 16 |
| 1999 | 0 | 25 | 25 |
| 2000 | 0 | 21 | 21 |
| 2001 | 0 | 21 | 21 |
| 2002 | 0 | 34 | 34 |
| 2003 | 0 | 33 | 33 |
| 2004 | 0 | 36 | 36 |
| 2005 | 0 | 43 | 43 |
| 2006 | 0 | 37 | 37 |
| 2007 | 0 | 34 | 34 |
| 2008 | 0 | 41 | 41 |
| 2009 | 0 | 55 | 55 |
| 2010 | 0 | 34 | 34 |
| 2011 | 0 | 59 | 59 |
| 2012 | 0 | 51 | 51 |
| 2013 | 0 | 47 | 47 |
| 2014 | 0 | 79 | 79 |
| 2015 | 0 | 56 | 56 |
| 2016 | 0 | 37 | 37 |
| 2017 | 0 | 61 | 61 |
| 2018 | 0 | 59 | 59 |
| 2019 | 0 | 49 | 49 |
| 2020 | 0 | 51 | 51 |
| 2021 | 0 | 50 | 50 |
| 2022 | 0 | 46 | 46 |
| 2023 | 0 | 40 | 40 |
| 2024 | 0 | 46 | 46 |
| 2025 | 0 | 11 | 11 |
To return to the timeline,
click here.
Below are the most recent publications written about "Double-Blind Method" by people in Profiles.
-
BIO101 in Sarcopenic Seniors at Risk of Mobility Disability: Results of a Double-Blind Randomised Interventional Phase 2b Trial. J Cachexia Sarcopenia Muscle. 2025 Apr; 16(2):e13750.
-
Pitavastatin Is Well-Tolerated With no Detrimental Effects on Physical Function. Clin Infect Dis. 2025 Feb 24; 80(2):425-433.
-
Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized Trial. J Am Heart Assoc. 2025 Mar 04; 14(5):e038656.
-
Metabolic Effects of Testosterone Added to Intensive Lifestyle Intervention in Older Men With Obesity and Hypogonadism. J Clin Endocrinol Metab. 2025 Feb 18; 110(3):e814-e826.
-
Long-Term Safety and Efficacy of Esmethadone in Patients With Major Depressive Disorder: Findings From a 12-Month Open-Label Study. J Clin Psychiatry. 2025 Feb 17; 86(1).
-
Diagnoses supported by a computerised diagnostic decision support system versus conventional diagnoses in emergency patients (DDX-BRO): a multicentre, multiple-period, double-blind, cluster-randomised, crossover superiority trial. Lancet Digit Health. 2025 Feb; 7(2):e136-e144.
-
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials. Lancet Respir Med. 2025 Mar; 13(3):234-243.
-
Randomized Controlled Trial of the Effects of High-Dose Ondansetron on Clinical Symptoms and Brain Connectivity in Obsessive-Compulsive and Tic Disorders. Am J Psychiatry. 2025 Mar 01; 182(3):285-296.
-
Larsucosterol for the Treatment of Alcohol-Associated Hepatitis. NEJM Evid. 2025 Feb; 4(2):EVIDoa2400243.
-
A randomized, placebo-controlled, cross-over trial of ketamine in Rett syndrome. J Neurodev Disord. 2025 Jan 24; 17(1):4.